Australian National Diabetes Information Audit & Benchmarking (ANDIAB) 2011 Final Report

What's New

A description of which features of the report are new since the previous report in 2009

Page last updated: December 2011

In ANDIAB 2011 we collected the same dataset as in 2009 with the addition of just 2 new fields related to eGFR (see below).

In ANDIAB 2009 there were several changes to the collection in response to feedback from participants in previous ANDIAB collections, and a review of experience in the 2006 Diabetes Collaborative. The aim of that project was to conduct a National Breakthrough Collaborative of Diabetes Centres that had participated in several ANDIAB data collections, in order to develop clinical practice strategies to improve diabetes care. The Collaborative specifically explored the barriers to achieving therapy targets, attempted to address these at health professional and patient levels, and specifically attempted to impact on Blood Pressure and Lipid Status of referred patients. The ultimate goal was to implement strategies to impact positively on diabetes care and outcomes. In 2006, ANDIAB followed the lead of the Collaborative, and collected more data on Blood Pressure and Lipid therapies and omitted Eye and Feet data completely.

In 2009, some, but not all, of the enhancements to Antihypertensive and Lipid Therapy data from 2006 were retained, Aspirin / Clopidogrel Therapy items were again collected, as was the expanded Smoking Status item of Current, Past or Never. Eye and Foot data items, as collected in 2004, returned. Also as in 2006, The Brief Case-find for Depression [BCD] and two items on Psychiatric Treatment / Counseling – Current {Yes/No} and Previous {Yes/No}, previously collected, were not included (but were collected in ANDIAB2 2010). The new data issue relevant to ANDIAB 2009 was the decision to collect information on specific Diabetes Tablet Therapies and was retained in 2011.

The previously created separate data collection ‘Paediatric/Adolescent’ form for individuals aged eighteen years or less, containing data items of most relevance to them, was not utilized, as Specialist Paediatric sites did not participate in 2011.

Thus, the only enhancement made to the dataset in 2011 was the addition of the following data items eGFR>60 {Yes/No}, and eGFR Result.

The previously created form sent to each participating site requesting Upper Limit of Normal Data for HbA1c and Microalbumin/Protein [and Units] was again utilised – enabling these data to be entered once into the central database. [This successfully produced 100% HbA1c Upper Limit data - but still less than completely analysable Microalbumin data, as forms did not always contain the Units relevant to the result provided in order to apply the Upper Limit obtained from that site].

In ANDIAB 2011, seven sites provided data from in-house databases, however, no sites provided data from ANDIAB Software. One strategy undertaken previously by several ANDIAB sites had been to use ANDIAB Software in order to complete an ‘annual review’ on several [rather than all] patients per clinic, which would enable their site to build up their database over time, and remove one of the perceived burdens of ANDIAB – the need to complete forms on all [or almost all] patients seen in the one month survey period. Four sites provided data from ANDIAB Software in 2002 and nine in 2004, but just one in 2006. It had been hoped that as more sites use this tool, the potential existed to extract data more frequently and provide comparative audit reports, perhaps again on an annual basis. This goal could still be achieved as more sites develop in-house databases from which an ANDIAB data extract can be obtained. It is apparent that use of ANDIAB software waned and has now ceased, likely due in part to the fact that it was never designed to be a day-to-day patient management database solution. Clearly however, the majority of sites still do not have a database from which they can extract ANDIAB data.

Document download

This publication is available as a downloadable document.

Australian National Diabetes Information Audit & Benchmarking (ANDIAB) 2011 Final Report(PDF 559 KB)